Skip to main content

MediWound Ltd. (MDWD)

Sector
Healthcare
Industry
Biotechnology
Last price
$13.55
As of

Kresmion compiles this page from MDWD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

MediWound Ltd. (MDWD): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-11-12.

As of . Source: SEC EDGAR filings for MDWD. Method and limitations.

COMPANY DOSSIER

See the full MDWD dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for MDWD on one page. Preview it with sample data, then open it live with a free account.

Preview the MDWD dossier

Active events for MDWD

  • mediumEarnings above estimates

    Q3-2026: Beat consensus by 9.8%, EPS $-0.65 vs $-0.7208 estimate

  • high13F: large increase

    Point72 Asset Management, L.P. added +188% to MDWD (2026Q1)

  • mediumEarnings above estimates

    Q1-2026: Beat consensus by 65.6% - EPS $-0.23 vs $-0.6681 estimate

  • mediumEarnings below estimates

    Q2-2025: Missed consensus by 110.9% - EPS $-1.23 vs $-0.5831 estimate

  • mediumEarnings above estimates

    Q3-2025: Beat consensus by 71.0% - EPS $-0.24 vs $-0.8279 estimate

FREE, NO ACCOUNT

Every event on MDWD, as it fires

You are seeing 5 of 7 events recorded on MDWD since 2026-06-05.

The five above landed across 4 days. The other 2 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, MDWD

More data on MDWD

MDWD against its peers

MDWD's operating margin of -149.0% ranks in the 59th percentile of 15 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.

MetricMDWDPeer medianPercentilen
Revenue FY17.0M USD16.6M USD5016
Revenue YoY-16.1%-15.9%425
Gross margin19.2%82.8%197
Operating margin-149.0%-221.7%5915
Net margin-140.8%-233.7%6216
Return on equity-54.7%-40.0%4622
1 year-24.1%-6.7%4224

Peers (24): KRRO, PYXS, WHWK, SLGL, KROS, ANIK, ELDN, RNAC, ARTV, CGEN, PRQR, TRDA, ANTX, ACOG, IFRX, BBOT, IVVD, PALI, NGEN, ZNTL, NAGE, STRO, ACIU, IKT. Left out: HSTC (period gap). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (MDWD: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in MDWD on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on MDWD in the last 180 days.

Upstream: SEC EDGAR filings for MDWD

Kresmion, "MediWound Ltd. (MDWD) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/MDWD. Upstream data: SEC EDGAR filings for MDWD.

Link to this data (HTML):

<a href="https://kresmion.com/research/MDWD">MediWound Ltd. (MDWD) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow MDWD on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to MDWD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the MDWD dossier
Share

The MDWD intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.